97113 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus Paramyxoviridae, e.g. respiratory syncytial virus
Fusions of antibodies to CD38 and attenuated interferon alpha
#302METHOD FOR INCREASING N-GLYCOSYLATION SITE OCCUPANCY ON THERAPEUTIC GLYCOPROTEINS PRODUCED IN PICHIA PASTORIS
#303Rapid clearance of antigen complexes using novel antibodies
#304Recombinant carrier molecule for expression, delivery and purification of target polypeptides
#305Protein formulations containing amino acids
#306Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
#307RSV specific binding molecule
#308Human monoclonal antibodies against Hendra and Nipah viruses
#309RSV-specific binding molecules and means for producing them
#310Neutralizing Antiboides to Nipah and Hendra Virus
#311Stabilized liquid anti-RSV antibody formulations
#312Antibodies against human respiratory syncytial virus (RSV) and methods of use
#313Antibodies that neutralize RSV, MPV and PVM and uses thereof
#314Devices and methods for detecting human metapneumovirus
#315Recombinant mumps virus vaccine
#316Monoclonal antibody production by EBV transformation of B cells
#317Respiratory syncytial virus vaccine
#318Feline morbillivirus and uses thereof
#319Anti-human respiratory syncytial virus (RSV) antibodies and methods of use
#320Soluble forms of Hendra and Nipah virus G glycoprotein
#321Soluble forms of hendra and nipah virus G glycoprotein
#322Human Monoclonal Antibodies Against Hendra and Nipah Viruses
#323Pulmonary administration of immunoglobulin single variable domains and constructs thereof
#324TRAIL R2-specific multimeric scaffolds
#325Anti-RSV G protein antibodies
#326Human respiratory syncytial virus vaccine
#327Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in
#328Stabilized liquid anti-RSV antibody formulations
#329RSV IMMUNOGENS, ANTIBODIES AND COMPOSITIONS THEREOF
#330Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
#331Recombinant carrier molecule for expression, delivery and purification of target polypeptides
#332SILICA NANOPARTICLES WITH ROUGH SURFACE
#333Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Nipah Infections
#334Compositions And Methods Involving Respiratory Syncytial Virus Subgroup B Strain 9320
#335Topical Methods Of Treating RSV Infections And Related Conditions
#336Compositions and methods for modulating RSV infection and immunity
#337Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS
#338RSV F PROTEIN COMPOSITIONS AMD METHODS FOR MAKING SAME
#339Means and methods for producing high affinity antibodies
#340Human-murine chimeric antibodies against respiratory syncytial virus
#341ULTRA HIGH AFFINITY NEUTRALIZING ANTIBODIES
#342Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
#343Neutralizing monoclonal antibodies to respiratory syncytial virus
#344METHODS OF ADMINISTERING / DOSING ANTI-RSV ANTIBODIES FOR PROPHYLAXIS AND TREATMENT
#345RSV specific binding molecule
#346Human monoclonal antibodies against hendra and nipah viruses
#347STABILIZED ANTI-RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIBODY FORMULATIONS
#348Stabilized liquid anti-RSV antibody formulations
#349MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS
#350Methods for Recombinant Manufacturing of Anti-RSV Antibodies
#351Antibody composition with altered Fab sialylation
#352RECOMBINANT EXPRESSION OF SELF-FOLDING NEUTRALIZING EPITOPE-BEARING SUBDOMAINS OF THE RESPIRATORY SYNCYTIAL VIRUS ATTACHMENT AND FUSION PROTEINS
#353Fusogenic virus-like particles and uses thereof
#354PULMONARY ADMINISTRATION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND CONSTRUCTS THEREOF
#355RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
#356Crystals and structure of a human IgG Fc variant with enhanced FcRn binding
#357Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
#358RECOMBINANT ANTIBODIES FOR TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
#359Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
#360Systems and methods for antibody engineering
#361METHODS OF PREVENTING AND TREATING RSV INFECTIONS AND RELATED CONDITIONS
#362HUMAN ANTIBODIES NEUTRALIZING HUMAN METAPNEUMOVIRUS
#363Antibodies against human respiratory syncytial virus (RSV) and methods of use
#364Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof
#365Stabilized liquid anti-RSV antibody formulations
#366Methods of Treating RSV Infections And Related Conditions
#367Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#368Recombinant RSV antigens
#369Anti-RSV G protein antibodies
#370ANTIBODY FORMULATIONS HAVING OPTIMIZED AGGREGATION AND FRAGMENTATION PROFILES
#371Antibodies against and methods for producing vaccines for respiratory syncytial virus
#372Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
#373ULTRA HIGH AFFINITY NEUTRALIZING ANTIBODIES
#374DETECTION OF CELL SURFACE BINDING MOLECULES USING A PHAGE DISPLAY BLOCKING ASSAY
#375VESICULAR PHOSPHOLIPID GELS COMPRISING PROTEINACEOUS SUBSTANCES
#376RSV-specific binding molecules and means for producing them
#377Antibodies Against Mammalian Metapneumovirus
#378High potency recombinant antibodies and method for producing them
#379Recombinant carrier molecule for expression, delivery and purification of target polypeptides
#380CHIMERIC ANTIGENS
#381Metapneumovirus strains and their use in vaccine formulations and sequences
#382MOLECULES WITH REDUCED HALF-LIVES, COMPOSITIONS AND USES THEREOF
#383METHODS OF PREVENTING AND TREATING RSV INFECTIONS AND RELATED CONDITIONS
#384Multi-modal cancer therapy using viral hitch-hiking
#385METHOD FOR DETECTING MEASLES VIRUS, MEMBRANE ASSAY TEST DEVICE, AND MEMBRANE ASSAY TEST KIT
#386Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
#387Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
#388Monoclonal antibody production by EBV transformation of B cells
#389RS VIRUS DETECTING KIT USING ANTI-RS VIRUS MONOCLONAL ANTIBODY, IMMUNO-CHROMATOGRAPHIC TEST DEVICE, AND NEW ANTI-RS VIRUS MONOCLONAL ANTIBODY
#390Nucleic acids encoding respiratory syncytial virus subgroup B strain 9320
#391Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#392Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#393Human monoclonal antibodies against Hendra and Nipah viruses
#394MEASLES SUBUNIT VACCINE
#395Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
#396Methods for recombinant manufacturing of anti-RSV antibodies
#397Anti-RSV G protein antibodies
#398Methods for use in human-adapting monoclonal antibodies
#399Neutralizing monoclonal antibodies to respiratory syncytial virus
#400Human-murine chimeric antibodies against respiratory syncytial virus
#401Monoclonal antibodies to respiratory syncytial virus and uses therefor
#402Soluble forms of Hendra and Nipah virus G glycoprotein
#403MACROMOLECULES COMPRISING A THIOETHER CROSS-LINK
#404Stabilized liquid anti-RSV antibody formulations
#405Recombinant antibodies for treatment of respiratory syncytial virus infections
#406Molecules with extended half-lives, compositions and uses thereof
#407Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#408Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
#409Systems and Methods for Antibody Engineering
#410IMMUNOGENIC AGENT THERAPY USING PLASMAPHERESIS
#411Compositions and methods for human metapneumovirus monoclonal antibodies
#412Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
#413Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
#414Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses
#415Antibody formulations having optimized aggregation and fragmentation profiles
#416Combination Therapy Of Respiratory Diseases Using Antibodies
#417Interleukin-12 as an adjuvant for paramyxoviridae vaccines
#418Neutralizing High Affinity Human Monoclonal Antibodies Specific to RSV F-Protein and Methods for their Manufacture and Therapeutic use thereof
#419Stabilized liquid anti-RSV antibody formulations
#420Human-murine chimeric antibodies against respiratory syncytial virus
#421Recombinant carrier molecule for expression, delivery and purification of target polypeptides
#422Crystals and structure of Synagis Fab
#423Antibodies against mammalian metapneumovirus
#424Macromolecules comprising a thioether cross-link
#425Anti-respiratory syncytial virus antibodies, antigens and uses thereof
#426Methods of preventing and treating RSV infections and related conditions
#427Antibodies against and methods for producing vaccines for respiratory syncytial virus
#428Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses
#429Stabilized liquid anti-RSV antibody formulations
#430Compositions and methods for modulating RSV infection and immunity
#431RSV proteins, antibodies, compositions, methods and uses
#432Combination therapy of respiratory diseases using antibodies
#433Super-humanized antibodies against respiratory syncytial virus
#434Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
#435Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
#436Human monoclonal antibody
#437Immunogenic agent therapy using plasmapheresis or exchange transfusion
#438Measles subunit vaccine
#439Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
#440Virus causing respiratory tract illness in susceptible mammals
#441Cellular virus receptors and methods of use
#442Escape mutants of newcastle disease virus as marker vaccines
#443Virus causing respiratory tract illness in susceptible mammals
#444Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
#445Human monoclonal antibodies
#446Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment